FIELD: medicine.
SUBSTANCE: biodegradable devices are described, such as implants for the controlled delivery of therapeutic agents, in particular large molecules such as proteins and antibodies. The devices contain a porous silicon carrier material impregnated with a therapeutic agent. An improved dosage form for controlled release of therapeutic agents can be used in vitro or in vivo to deliver the therapeutic agent during an estimated period of time, for example, several days, weeks or months.
EFFECT: device can be used to treat or prevent the patient's conditions, such as chronic diseases.
19 cl, 3 dwg, 6 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BIODEGRADABLE SILICONE-BASED COMPOSITIONS FOR DELIVERING THERAPEUTIC AGENTS | 2014 |
|
RU2705986C2 |
| DRUG DELIVERY DEVICE CONTAINING SILICON-BASED CARRIER PARTICLES | 2014 |
|
RU2695536C2 |
| PEPTIDYL-DIACYLGLYCERIDES | 2009 |
|
RU2545347C2 |
| BIOLOGICALLY RESOLVING COMPOSITION WITH CONTROLLED RELEASE | 2007 |
|
RU2405537C2 |
| COMPOSITIONS AND METHODS FOR PROTECTION AGAINST PATHOGENS AND IRRITANTS PRESENT IN AIR | 2017 |
|
RU2773149C2 |
| CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR THYMIC STROMAL LYMPHOPOIETIN RECEPTOR, AND METHODS FOR USE THEREOF | 2014 |
|
RU2701346C1 |
| RNA PARTICLES INCLUDING POLYSARCOZINE | 2019 |
|
RU2792644C2 |
| ANTAGONISTIC ANTIBODIES AGAINST THE IL-7 RECEPTOR AND METHODS | 2014 |
|
RU2653430C2 |
| M971 CHIMERIC ANTIGEN RECEPTORS | 2013 |
|
RU2658485C2 |
| ANTAGONIST ANTI-IL-7 RECEPTOR ANTIBODIES AND METHODS | 2011 |
|
RU2533809C9 |
